# Lisata Therapeutics, Inc.: Form 8-K, filed Oct 8, 2025

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2025-10-08
- Accepted by EDGAR: Oct 8, 2025, 15:12 ET
- Period: 2025-10-08
- Accession: 0000320017-25-000063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001725000063/clbs-20251008.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001725000063/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001725000063/clbs-20251008.htm

Filed Oct 8, 2025.
Source: SEC EDGAR, the filing index for accession 0000320017-25-000063. Last ingested by Listed: Nov 12, 2026, 17:18 ET. No prices; not investment advice.